Spearhead Capital Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,652	Closed	-$274K	–	178
2021 Q3	$274K	Sell	10,652 -425	-4%	-$10.9K	0.04%	162
2021 Q2	$289K	Buy	+11,077	New	+$289K	0.04%	179